Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Hôpital Henri Mondor, AP-HP, Unité de Recherche Clinique | UNKNOWN |
| Hôpital Avicenne, AP-HP, Service Hépatologie | UNKNOWN |
Not provided
Not provided
Not provided
The risk factors for liver cirrhosis are well identified and primarily include excessive and prolonged alcohol consumption, as well as metabolic syndrome or infection with hepatitis B and C viruses. However, the factors that can predict the progression of the disease are still largely unknown. The role of nutritional factors, in particular, has been insufficiently studied in chronic liver diseases such as cirrhosis. Beyond malnutrition and nutritional deficiencies, whose roles have been well studied, it appears that other nutritional factors, such as adherence to dietary recommendations that consider the consumption of various food groups, have been little studied in patients with liver cirrhosis. Studies involving a large number of participants are essential to better describe the typical nutritional profiles of these patients, taking into account their diet, as well as their alcohol consumption and physical activity.
Therefore, the main aim of the Nutri-CIRR project is to identify and characterize typical profiles of patients with hepatic cirrhosis in terms of nutritional factors (diet, alcohol consumption and physical activity) and smoking status.
The Nutri-CIRR study is an observational study taking place in France and assessing nutritional factors among patients with liver cirrhosis. After inclusion in the study, all patients are invited to complete validated online questionnaires on diet, alcohol consumption, physical activity, as well as socioeconomic and other lifestyle characteristics. Questionnaires are completed at one occasion.
The main aim of the Nutri-CIRR project is to identify and characterize typical profiles of patients with hepatic cirrhosis in terms of nutritional factors (diet, alcohol consumption and physical activity) and smoking status.
Secondary aims are:
To address secondary aims #2 and #3, data from the Nutri-CIRR study will be matched with data from the FASTRAK study (NCT05095714), which monitors the liver disease progression.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with liver cirrhosis | Patients with liver cirrhosis are included in the cohort |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Nutritional intakes | Usual macronutrient and micronutrient intakes, assessed with a validated food frequency questionnaire | At enrollment |
| Food group intakes | Usual intake of the main food groups, assessed with a validated food frequency questionnaire | At enrollment |
| Mediterranean diet score | Mediterranean diet score, assessed with a validated food frequency questionnaire | At enrollment |
| Alcohol intake | Usual alcohol intake, total and by type of alcoholic beverages, assessed with a validated food frequency questionnaire | At enrollment |
| Smoking status | Smoking status, number of pack-years, assessed by questionnaire | At enrollment |
| Physical activity | Duration of moderate and vigorous physical activity, duration of walking, physical activity level (low, moderate, high, calculated using the duration of moderate, vigorous physical activity and walking), assessed with the IPAQ short-form | At enrollment |
| Sedentary behavior | Sitting time, assessed with the IPAQ short-form | At enrollment |
| Weight |
| Measure | Description | Time Frame |
|---|---|---|
| Socioeconomic factors | Educational, level, occupation, income | At enrollment |
| Demographic factors | Gender, marital status, household composition, number of children |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with liver cirrhosis
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Alice Bellicha, PhD | Contact | 00(33)148388933 | a.bellicha@eren.smbh.univ-paris13.fr | |
| Laure Legris | Contact | 00(33)148388933 | laure.legris@eren.smbh.univ-paris13.fr |
| Name | Affiliation | Role |
|---|---|---|
| Alice Bellicha, PhD | Université Sorbonne Paris Nord | Principal Investigator |
Not provided
Data described in the article, code book, and analytic code will be made available upon request. Researchers of a public institution can submit a collaboration request including their institution and a brief description of their project to the principal investigator. All requests will be reviewed by the scientific team of the project. A financial contribution may be requested. If the collaboration is accepted, a data access agreement will be necessary and appropriate authorizations from the competent administrative authorities may be needed. In accordance with existing regulations, no personal data will be accessible.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D008103 | Liver Cirrhosis |
| ID | Term |
|---|---|
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
| D005355 | Fibrosis |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Self-reported body weight |
| At enrollment |
| Height | Self-reported height | At enrollment |
| Body mass index | Calculated as weight/(height*height) | At enrollment |
| Nutritional score | PNNS-GS2 is a nutritional score calculated using data on dietary intake, alcohol intake and physical activity. A higher score indicates a greater nutritional quality | At enrollment |
| At enrollment |
| Follow-up of cirrhotic disease (occurrence of hepatocellular carcinoma) | Occurrence of hepatocellular carcinoma. These data will be collected as part of a matching process with the FASTRAK study (NCT05095714) for patients included in both studies (Nutri-CIRR + FASTRAK) | From enrollment to the end of follow-up at 3 years |
| Follow-up of cirrhotic disease (other hepatic complications) | Occurrence of other hepatic complications (ascites, jaundice, bleeding due to portal hypertension, severe bacterial infections). These data will be collected as part of a matching process with the FASTRAK study (NCT05095714) for patients included in both studies (Nutri-CIRR + FASTRAK) | From enrollment to the end of follow-up at 3 years |
| Follow-up of cirrhotic disease (extra-hepatic complications) | Occurrence of extra-hepatic complications (cardiovascular events, extra-hepatic cancers). These data will be collected as part of a matching process with the FASTRAK study (NCT05095714) for patients included in both studies (Nutri-CIRR + FASTRAK) | From enrollment to the end of follow-up at 3 years |
| D013568 |
| Pathological Conditions, Signs and Symptoms |